Evaluation of bovine coronavirus in Korean native calves challenged through different inoculation routes
Veterinary Research,
Journal Year:
2024,
Volume and Issue:
55(1)
Published: June 11, 2024
Abstract
Bovine
coronavirus
(BCoV)
is
a
pneumoenteric
virus
that
can
infect
the
digestive
and
respiratory
tracts
of
cattle,
resulting
in
economic
losses.
Despite
its
significance,
information
regarding
BCoV
pathogenesis
limited.
Hence,
we
investigated
clinical
signs,
patterns
viral
shedding,
changes
antibody
abundance,
cytokine/chemokine
production
calves
inoculated
with
via
intranasal
oral.
Six
clinically
healthy
Korean
native
(<
30
days
old),
initially
negative
for
BCoV,
were
divided
into
oral
groups
monitored
15
post-infection
(dpi).
BCoV-infected
exhibited
signs
such
as
nasal
discharge
diarrhea,
starting
at
3
dpi
recovering
by
12
dpi,
being
most
common
symptoms.
Viral
RNA
was
detected
fecal
samples
from
all
infected
calves.
Nasal
shedding
occurred
before
regardless
inoculation
route;
however,
persisted
longer.
Although
number
partitions
very
few,
identified
blood
two
group
7
9
using
digital
RT-PCR
analysis.
The
effectiveness
maternal
antibodies
preventing
replication
appeared
Our
results
showed
interleukin
(IL)-8
highly
induced
chemokine.
During
infection,
levels
IL-8,
monocyte
chemoattractant
protein-1,
macrophage
inflammatory
protein-1β
significantly
affected,
suggesting
these
emerge
potential
reliable
biomarkers
predicting
infection.
This
study
underscores
importance
major
pathogen
causing
diarrhea
disease.
Language: Английский
Durability of Functional SARS‐CoV‐2‐Specific Immunological Memory and T Cell Response up to 8–9 Months Postrecovery From COVID‐19
Journal of Immunology Research,
Journal Year:
2025,
Volume and Issue:
2025(1)
Published: Jan. 1, 2025
Research
on
long‐term
follow‐up
in
individuals
who
have
recovered
from
coronavirus
disease‐19
(COVID‐19)
would
yield
insights
regarding
their
immunity
status
and
identify
those
need
booster
vaccinations.
This
study
evaluated
the
longevity
of
severe
acute
respiratory
syndrome
2
(SARS‐CoV‐2)‐specific
cellular
humoral
memory
responses,
as
well
T
cell
effector
functionalities,
at
1–2
months
(
n
=
40),
8–9
12
months/1
year
27)
following
recovery
SARS‐CoV‐2
infection.
CTL
response
by
enzyme‐linked
immunospot
(ELISPOT);
levels
cytokine
Bio‐Plex,
natural
killer
(NK),
CD4+
helper,
CD8+
cytotoxic
functionalities
using
flow
cytometry;
anti‐SARS‐CoV‐2
IgG
ELISA;
neutralizing
antibodies
(NAbs)
surrogate
virus
NAb
assay
were
assessed.
The
SARS‐CoV‐2‐specific
8−9
postrecovery
hand
appeared
declining.
B,
B
plasma
cells,
cells
sustained
up
to
months.
Increased
expression
CD107a/IFN‐γ
NK
could
be
indicative
functions.
Recovered
with
positive
negative
antibody
displayed
1
months,
respectively,
emphasizing
durabilty
regardless
status.
Overall,
exhibited
robust
immunological
memory,
functionality
against
that
persists
for
least
Language: Английский
Analysis of Differences in Lymphocyte Subsets and CD4+ T Cells Immune Activation Between Re-detectable Positive and Non-re-detectable Positive COVID-19 Convalescent Patients
Huang Zhi Min,
No information about this author
Li Lian,
No information about this author
Yang Zheng Rong
No information about this author
et al.
Archives of Clinical Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
19(1)
Published: Jan. 29, 2024
Background:
When
coronavirus
disease
2019
(COVID-19)
first
broke
out,
much
literature
was
reported
on
the
re-detectable
positive
phenomenon
of
COVID-19
patients
during
recovery;
however,
there
were
few
studies
lymphocyte
subsets,
T-lymphocyte
activation
indicators,
and
levels
specific
antibodies
between
(RP)
non-re-detectable
(NRP)
patients.
Objectives:
This
study
aimed
to
analyze
immunological
characteristics
RP
NRP
among
convalescent
from
post-discharge
explore
factors
related
RP.
Methods:
Anticoagulated
whole
blood
samples
collected
11
healthy
controls
(HCs)
66
Then,
percentage
subsets
CD4+CD38+/HLA-DR+
T
cells
tested
with
flow
cytometry,
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
anti-spike
protein
receptor-binding
domain
immunoglobulin
G
(S-RBD-IgG)
antibody
detected
by
chemiluminescence.
Results:
B
(%)
in
group
significantly
lower
than
that
HC
(P
=
0.014),
decreased
successively
HC,
NRP,
groups,
significant
differences
three
groups
0.016).
CD3+
CD8+
noticeably
higher
0.004
0.019,
respectively);
nevertheless,
no
difference
CD4+
natural
killer
(NK)
groups.
The
CD4+CD38+
CD4+HLA-DR+
0.013
0.025).
analysis
showed
HLA-DR+
also
different
0.037
0.015),
increased
turn.
Meanwhile,
a
correlation
RBD-IgG
titer
0.003,
r
0.517),
high
Low
0.005)
Conclusions:
In
this
study,
analyzed
based
relationship
S-RBD-IgG
activated
cells.
results
low
might
be
phenomenon,
play
crucial
role
responses.
Language: Английский
Humoral and cellular immune response to AZD1222 /Covishield and BV152/Covaxin COVID-19 vaccines among adults in India
Human Vaccines & Immunotherapeutics,
Journal Year:
2024,
Volume and Issue:
20(1)
Published: Oct. 21, 2024
Several
COVID-19
vaccines
were
developed
using
different
approaches
to
prevent
both
symptomatic
cases
and
fatalities.
The
adults
vaccinated
with
two
doses
of
AZD1222/Covishield
(n
=
77)
[manufactured
by
Serum
Institute
India
Pvt
Ltd]
vaccine
BV152/Covaxin
99)
Bharat
Biotech]
vaccine.
They
assessed
for
immune
response
at
pre-vaccination,
1
month
post
first
6
months
second
dose
anti-SARS-CoV-2
IgG
antibody,
surrogate
neutralizing
antibody
(NAbs),
phenotypes,
antigen
specific
NK,
B
T
cell
response,
their
effector
functionality
ELISPOT
plasma
cytokine
profile.
Both
elicited
enhanced
Nab
levels
compared
the
baseline.
BV152/Covaxin,
whole
virus
inactivated
exhibited
higher
(70%
vs
100%),
(90%
robust
(31%
96%)
responses
justifying
utility
dose.
Detection
SARS-CoV-2
WV
S1
CD4+
central
memory
in
vaccinee
CD8+
naïve
indicated
involvement
cells.
Persistent
NAb
along
IgG+B
IgG+memory
cells
recipients
sustained
response.
Continued
heightened
IFN-γ
secreting
(ELISPOT)
displayed
platforms
could
serve
as
a
co
correlate
protection,
further
evaluation
follow
up
studies.
Overall,
our
data
suggest
that
coordinated
functions
humoral
cellular
branches
adaptive
immunity
may
pave
ways
toward
protective
against
COVID-19.
Language: Английский